Advertisement

Topics

Maruishi gets rights to antiemetic in all-Japanese deal

11:18 EDT 7 Sep 2017 | thePharmaLetter

Maruishi Pharmaceutical is to pay fellow Japanese drugmaker Sumitomo Dainippon Pharma for exclusive development,…

Original Article: Maruishi gets rights to antiemetic in all-Japanese deal

NEXT ARTICLE

More From BioPortfolio on "Maruishi gets rights to antiemetic in all-Japanese deal"

Quick Search
Advertisement